Quadriblock Versus "IPACK + Femoral Triangle Block + Obturator Nerve Block" in Total Knee Arthroplasty
Launched by CLINIQUE MEDIPOLE GARONNE · Aug 4, 2020
Trial Information
Current as of June 28, 2025
Completed
Keywords
ClinConnect Summary
In the pre-anaesthesia room, after the implementation of classical monitoring with an oxygen mask and a peripheral venous catheter, all patients will receive an antibioprophylaxis according to SFAR (French Society of Anesthesia \& Intensive Care Medecine) recommendations and injection of 10 mg of IV dexamethasone.
The patients will be then randomized in 2 groups:
* ITO group (usual technique): IPACK combined to femoral triangle and obturator nerve blocks
* Quadriblock group (experimental technique): femoral, sciatic, obturator and lateral femoral cutaneous nerve blocks.
An experienced an...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years and older,
- • Primary total knee arthroplasty
- • Consent for participation,
- • Affiliation to a social security system
- Exclusion Criteria:
- • Preoperative morphine use
- • Chronic pain syndrome
- • Contraindication to any drugs used in the protocol (paracetamol, ketoprofen, oxynorm, propofol, ketamine, ropivacaine)
- • Valgus \> 9°
- • Pregnant or breastfeeding women
- • Patients under protection of the adults (guardianship, curators or safeguard of justice)
About Clinique Medipole Garonne
Clinique Medipole Garonne is a leading healthcare institution dedicated to advancing medical research and enhancing patient care through innovative clinical trials. Located in France, the clinic specializes in a range of medical disciplines and is committed to adhering to the highest ethical standards and regulatory compliance. With a focus on patient safety and well-being, Clinique Medipole Garonne collaborates with healthcare professionals and researchers to facilitate the development of new therapies and treatments, contributing to the global advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toulouse, Haute Garonne, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials